BOSTON, May 14 /PRNewswire-FirstCall/ -- Experts from PAREXEL Consulting will present insights into achieving regulatory approval at the BIO International Convention, to be held May 18-21, 2009 at the Georgia World Congress Center in Atlanta, Georgia. PAREXEL Consulting is a business unit of PAREXEL International (Nasdaq: PRXL) and leading global consultancy serving the biopharmaceutical and medical device industries. PAREXEL Consulting experts will be on site at the convention to discuss all aspects of biologics development and commercialization, portfolio analysis, and acquisition due diligence with attendees. For more information about these topics visit http://www.parexelconsulting.com/BIO2009.
On Tuesday, May 19 of the convention, PAREXEL Consulting experts will give presentations on the following panels, which are part of the Achieving Regulatory Approval Breakout Session:
-- Regulatory Best Practices for Emerging Companies and First-Time Filers
Panelist: David Morse, Principal Consultant, PAREXEL Consulting
(8:00 a.m. - 9:30 a.m.)
-- Is Gaining Drug Approval More Difficult in Europe than the U.S., or Vise Versa?
Panelist: Alberto Grignolo, Ph.D., Corporate Vice President, PAREXEL Consulting
(4:00 p.m. - 5:30 p.m.)
PAREXEL has worked with the top 10 global biotechnology companies, and has helped hundreds of small and mid-size biopharmaceutical companies develop and implement product and regulatory strategies as well as maximize product value at every milestone and phase of development. For information regarding PAREXEL Consulting's development optimization capabilities, including regulatory services, visit
|SOURCE PAREXEL International Corporation|
Copyright©2009 PR Newswire.
All rights reserved